bisphosphonate + hyaluronidase (Halozyme)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namebisphosphonate + hyaluronidase (Halozyme)
Drug Alias Namebisphosphonate (Halozyme)bisphosphonate (Halozyme)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionHyaluronidase stimulants
TargetsHyaluronidase
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHalozyme Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHalozyme Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A